INTRODUCTION
Prion diseases or transmissible spongiform encephalopathies are a group of neurodegenerative disorders including scrapie in sheep, bovine spongiform encephalopathy in cattle, Creutzfeldt-Jakob disease and GerstmannSträussler-Scheinker disease in humans [1] . In prion diseases the normal cellular form of the prion protein (PrP C ) undergoes a conformational conversion to the β-sheet-rich scrapie isoform (PrP Sc ) that is partially resistant to protease digestion. Although PrP C is critical for the development of prion disease through its conversion into PrP Sc [2, 3] , the physiological role of PrP C is less clear and thus it is uncertain whether prion diseases are, in part, due to the loss of a normal neuroprotective function of PrP C [4] . In the brains of animals at the terminal stage of illness there is a marked decrease of PrP C supporting the hypothesis that loss of function of PrP C may play a role in the pathogenesis of prion diseases [5] .
Amongst the neuroprotective functions of PrP C are roles in copper homeostasis and the cellular resistance to oxidative stress [6, 7] . PrP C binds Cu 2+ ions, primarily within the N-terminal octapeptide repeats [8] [9] [10] , undergoes endocytosis upon exposure of cells to Cu 2+ [11, 12] and modulates neuronal Cu 2+ content [13] , implicating PrP C in cellular copper metabolism. Cells deficient in PrP C are less viable in culture compared with cells expressing wild-type (wt) PrP and are more susceptible to oxidative damage and toxicity caused by reactive oxygen species (ROS) [14] [15] [16] [17] , implicating PrP C in the cellular response to oxidative stress. However, the mechanism by which PrP C mediates this protective effect is not known.
PrP
C is a glycosyl-phosphatidylinositol (GPI) anchored glycoprotein that undergoes a variety of proteolytic processing events. The protein can be cleaved at amino acids 110/111 to produce a 17 kDa C-terminal fragment C1 and a corresponding N-terminal fragment N1 [18] [19] [20] [21] . This processing has been referred to as α-cleavage [22] and may be mediated by ADAM 10 and ADAM 17, members of the ADAM (a disintegrin and metalloprotease) family [23] . PrP C can also be cleaved within or adjacent to the octapeptide repeats to generate a 21 kDa Cterminal fragment C2 and the corresponding Nterminal fragment N2 [18, 21, 24] . This cleavage event appears to be mediated by ROS [25] and has been termed β-cleavage [22] . In addition, we have recently shown that PrP C is proteolytically shed from the cell surface by a zinc metalloprotease that has similar properties to the α-secretase cleavage of the Alzheimer's amyloid precursor protein [26] . Understanding the role of these proteolytic cleavages and of the fragments generated is critical to a full understanding of the biological functions of PrP and may also impact on the role of the protein in prion diseases.
However, the role of the β-cleavage in the function of PrP C has not been addressed. In the current study we show that PrP expressed in the human neuroblastoma SH-SY5Y cell line undergoes both α-and β-cleavage, that β-cleavage is increased upon exposure of the cells to ROS, occurs at the cell surface and can be inhibited by a free radical quencher. We also show that β-cleavage does not occur in a mutant of PrP that lacks the octapeptide repeats (PrP∆oct) nor in two disease-associated mutants of PrP (PG14 and A116V). This lack of β-cleavage of the PrP mutants correlates with the sensitivity of cells to ROS indicating that this cleavage event may be part of the mechanism by which PrP C protects cells against oxidative stress.
EXPERIMENTAL PROCEDURES cDNA constructs and cell culture
The construction of wtPrP, PrP∆oct and PG14 in pIRESneo has been described previously [12] . A116V was generated from wtPrP using the Quikchange Site-Directed Mutagenesis Kit (Stratagene) with the following primers: sense 5'-CAGGGGCTGCGGTAGCTGGGGGCAGTAG -3'; antisense 5'-CTACTGCCCCAGCTACCGCAGCCCCTG-3' and the resulting construct verified by DNA sequencing. Human neuroblastoma SH-SY5Y cells were cultured, transfected by electroporation and pooled, stable cell lines obtained by antibiotic selection as described previously [27] . Copper was routinely administered to the cells as CuSO 4 in the presence of fetal calf serum (FCS) to provide a source of both albumin and histidine for the Cu 2+ to complex to. When the cells had reached confluency, the monolayer was washed twice with OptiMEM before incubation with the relevant compounds for the specified periods of exposure in OptiMEM. Cells were harvested into phosphate-buffered saline (PBS; 1.5 mM KH 2 PO 4 , 2.7 mM Na 2 HPO 4 , 150 mM NaCl, pH 7.4) pelleted by centrifugation at 1000g for 5 min and resuspended in lysis buffer (10 mM Tris/HCl, pH 7.8, 0.5% (w/v) sodium deoxycholate, 0.5% (v/v) Nonidet P-40, 100 mM NaCl, 10 mM EDTA, supplemented with complete protease inhibitor cocktail). The protein content of each lysate was determined using bicinchoninic acid in a microtitre plate assay with bovine serum albumin as standard [28] .
Surface biotinylation and immunoprecipitation
Cells at confluency were incubated for 1 h at 4°C with 0.5 mg/ml Biotin sulfo-NHS, washed 3 times with 50 mM glycine to quench the biotinylation reaction and then incubated for various times at 37°C in the absence or presence of 10 µM CuSO 4 and 100 µM H 2 O 2 in OptiMEM. Cell lysates were made 1% (w/v) with respect to N-lauroylsarcosine and incubated for 30 min with 0.5% (w/v) protein A-Sepharose. The protein A-Sepharose was pelleted by centrifugation for 1 min at 13,000g and the supernatant incubated overnight at 4°C with 0.1% (v/v) 3F4 antibody. Protein ASepharose was added to 0.5% (w/v) and incubation continued for 1 h. The immunocomplexes were pelleted by centrifugation at 13,000g for 1 min and washed three times with 150 mM NaCl, 0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 50 mM Tris/HCl, pH 8.0, 1% (v/v) Nonidet P-40. The remaining pellet was resuspended in dissociation buffer for analysis by SDS-PAGE and Western blot. To measure copper-induced endocytosis, biotin-labelled cells were incubated for 30 min at 37 o C in the absence or presence of 100 µM CuSO 4 presented as a histidine chelate. PrP remaining at the cell surface was removed by digestion with trypsin as previously described [12] .
Enzymic deglycosylation, SDS-PAGE and western blot analysis
Samples were deglycosylated with Peptide:Nglycosidase F (PNGase F) (Europa Bioproducts, Ely, UK) for 16 h at 37°C as described previously [27] . Where indicated samples were digested with 5µg/ml proteinase K for 1 h at 37 o C. Samples (containing 15 µg of total protein) or immunoprecipitates were resolved by electrophoresis through 14.5% polyacrylamide gels. For western blot analysis, resolved proteins were transferred to a Hybond-P poly(vinylidene) difluoride membrane (Amersham, Little Chalfont, U.K.). The membrane was blocked by incubation for 1 h with PBS containing 0.1% (v/v) Tween 20 and 5% (w/v) dried milk powder. Incubations with primary antibodies 3F4 (Signet Laboratories, Inc., Dedham, MA), SAF32 (Cayman Chemical, Ann Arbor, MI), 6H4 (Prionics, Zurich, Switzerland) or anti-actin and peroxidase-conjugated secondary antibodies were performed for 1 h in the same buffer. Incubation with peroxidase-conjugated streptavidin was performed for 1 h in PBS containing 0.1% (v/v) Tween-20. Bound peroxidase-conjugates were visualised using an enhanced chemiluminescence detection system (Amersham).
Recombinant calpain activity assay
The activity of 20 nM recombinant Calpain-2 (Calbiochem) was measured using 5 µM (FAM)-Gly-Gly-Gly-Gln-Leu-Tyr-Gly-Gly(DPA)-ArgArg-Lys(TAMRA)NH 2 (a gift from GlaxoSmithKline, Harlow, UK) in 60 mM imidazole/HCl, 5 mM L-Cysteine, 2.5 mM glutathione (reduced) and 5 mM CaCl 2 , pH 7.3. The broad spectrum calpain inhibitor N-AcetylLeu-Leu-Met-CHO (ALLM) resuspended in either DMSO or EtOH was added at 1, 10 or 100 µM. Activity was recorded as fluorescence released following cleavage of the substrate over 1 h using a Synergy HT (Bio-Tek) with excitation at 485 nm and emission at 528 nm. The data was expressed as the percentage inhibition of activity compared with the uninhibited control. 
Immunofluorescence microscopy

Measurement of intracellular oxidative activity and glutathione peroxidase activity
The level of intracellular free radicals was determined following exposure of the cells to H 2 O 2 (100 µM), CuSO 4 (8 µM) or both reagents in 5% FCS-containing medium for 6 h using 100 µM dihydrodichlorofluorescein diacetate (DCF-DA) as described previously [17] . Glutathione peroxidase activity was measured using 50 mM Na 2 HPO 4 /NaH 2 PO 4 , pH 7.0, 1 mM EDTA, 1 mM NaN 3 , 0.2 mM NADPH, 1 mM glutathione and 1 U/ml glutathione reductase at room temperature upon the addition of 0.1 ml cumene hydroperoxide (1.5 mM) as described previously [17] .
Statistical analysis
All analyses were subject to Kruskal-wallis nonparametric one-way analysis of variance. p < 0.001 were considered highly significant. Changes in cell number, intracellular radical generation and glutathione peroxidase activity in the cells expressing the mutant PrPs are all compared against wtPrP expressing cells.
RESULTS
PrP
C in SH-SY5Y cells is subject to α-and β-cleavages The proteolytic processing of murine PrP C containing the 3F4 epitope (wtPrP) stably expressed in the human neuroblastoma SH-SY5Y cell line was examined using antibodies that recognise different epitopes in the protein (Fig. 1) . To remove the problems of interpreting the immunoblots because of the variable glycosylation states of full-length PrP and of the C-terminal fragments, samples were deglycosylated prior to immunoblotting. Antibody SAF32, which recognises an epitope within the octapeptide repeats, as expected detected full-length PrP but neither the C1 nor C2 fragments in the cell lysate (Fig. 1B) . Antibody 3F4, which recognises the engineered epitope MHKM (residues 108-111 of murine PrP), detected both full-length PrP and the C2 fragment of molecular weight 21 kDa but not the C1 fragment as α-cleavage destroys the epitope recognised by this antibody (Fig. 1C) [20, 21] . Antibody 6H4, which recognises an epitope in the C-terminal half of the protein (residues 144-152), detected full-length PrP, C2 and the C1 fragment of molecular weight 17 kDa (Fig. 1D) . Although the C1 fragment was detected at a similar level of intensity as full-length PrP, the C2 fragment was present at a significantly lower level. These data indicate that in SH-SY5Y cells PrP C is subject to both α-and β-proteolytic cleavages to generate C1 and C2 fragments, respectively, as reported for other cell lines and in brain tissue [19] [20] [21] [22] .
β-cleavage of PrP
C is upregulated when cells are subjected to oxidative stress As there is some evidence to suggest that β-cleavage of PrP C is mediated by ROS [25] , we examined the effect of H 2 O 2 and Cu 2+ on the formation of the C2 fragment (Fig. 2 ). Changing the cell medium from serum-containing to serum-free OptiMEM caused an increase in the production of C2 ( Fig. 2A and D) due to the removal of survival factors on withdrawal of the serum from the medium [15] . In the presence of 100 µM H 2 O 2 and 10 µM Cu 2+ there was a further increase in the level of C2 above that observed in the serum-free medium treated cells within 10 min ( Fig. 2A and D) . In contrast to the changes in C2, the levels of neither full-length PrP ( Fig. 2B and E) nor the C1 fragment ( These observations indicate that ROS increased the production of C2 via β-cleavage but had no effect on α-cleavage. To confirm that β-cleavage of PrP C is indeed a ROS-mediated event, the effect of the hydroxyl radical quencher DMSO was examined (Fig. 3) . When cells expressing wtPrP were incubated in serum-free OptiMEM in the presence of DMSO, there was a dosedependent reduction in the production of C2 ( Fig. 3A and C) consistent with β-cleavage being a ROS-mediated process.
ROS-mediated β-cleavage of PrP
C occurs at the cell surface To determine whether cell surface PrP C was subject to ROS-mediated β-cleavage, cells expressing wtPrP were first surface biotinylated prior to treatment with 100 µM H 2 O 2 and 10 µM Cu 2+ (Fig. 4) . Following immunoprecipitation of PrP with antibody 3F4, biotinylated full-length PrP and C2 were visualised by immunoblotting with peroxidase-conjugated streptavidin. Immediately following biotinylation, negligible biotinylated C2 was detected in the cell lysate, although significant amounts of biotinylated fulllength PrP were present. However, an increase in the level of biotinylated C2 fragment was clearly evident following incubation of the cells in serum-free OptiMEM for 10 min, and this was further increased upon treatment of the cells with H 2 O 2 and Cu 2+ indicating that C2 is formed from PrP C exposed at the cell surface.
The octapeptide repeats are required for the ROS-mediated β-cleavage of PrP C
To determine whether ROS-mediated β-cleavage of PrP C required the octapeptide repeats, we examined the proteolytic processing of PrP∆oct that lacks the copper-binding octapeptide repeat region [12] (Fig. 5A) . Lysates from cells expressing PrP∆oct were subjected to immunoblot analysis with antibodies SAF32, 3F4 and 6H4 (Fig. 5B-D) . SAF32 failed to detect PrP∆oct as this mutant lacks the epitope for this antibody but was detected by 3F4 and 6H4. Although antibody 6H4 clearly detected the C1 fragment in cells expressing PrP∆oct, neither antibody 6H4 nor 3F4 detected the C2 fragment. These data indicate that the octapeptide repeats are required for PrP C to undergo β-cleavage.
ROS-mediated β-cleavage is defective in two disease-associated mutants of PrP
We examined next the proteolytic processing of two disease-associated mutants of PrP. PG14 contains an extra 9 copies of the octapeptide repeat and is associated with familial human prion disease [29, 30] and A116V in which Ala 116 (murine PrP numbering, equivalent to Ala 117 in human PrP) is mutated to Val and is associated with Gerstmann-Sträussler-Scheinker disease [31] (Fig. 5A) . Lysates from cells expressing the two mutants were subjected to immunoblot analysis with antibodies SAF32, 3F4 and 6H4 (Fig. 5B-D) . Although in cells expressing either PG14 or A116V all three antibodies detected full-length protein and 6H4 detected the C1 fragment, there was no detection of the C2 fragment in either cell line by antibodies 3F4 or 6H4 even after prolonged exposure of the immunoblots ( Fig. 5B and D) . Even upon treatment of the cells expressing PG14 or A116V with H 2 O 2 and Cu 2+ for up to 60 min there was no evidence for the production of C2, whereas under identical conditions C2 was clearly formed in cells expressing wtPrP (data not shown). These data indicate that in cells expressing two disease-associated mutants of PrP, although C1 is formed normally, C2 is not formed upon exposure of the cells to ROS.
One possible explanation for the lack of ROSmediated β-cleavage in cells expressing either PG14 or A116V is that the mutants fail to traffic to the cell surface where this processing occurs. Previously, however, we [12] and others [32] have shown by surface biotinylation and immunofluorescence microscopy that PG14 is localised at the cell surface. Although, the A116V mutant is expressed at a lower level than wtPrP in the SH-SY5Y cells (Fig. 6A) , the amount of this mutant at the cell surface as revealed by surface biotinylation was very similar to that of wtPrP (Fig. 6B) . The cell surface localisation of A116V was confirmed by immunofluorescence microscopy (Fig. 6C) . Like wtPrP, the A116V construct gave a similar pattern of cell surface staining which could be abolished by incubation of the cells with bacterial PI-PLC which cleaves the GPI anchor releasing the protein from the membrane. As neither the PrP∆oct nor the PG14 mutants are endocytosed when cells are exposed to Cu 2+ ions [12] , we considered that the lack of β-cleavage may correlate with a deficiency in coppermediated endocytosis. However, when cells expressing A116V were exposed to a concentration of Cu 2+ ions sufficient to promote endocytosis of wtPrP [12] , this mutant was rapidly endocytosed (Fig. 6D) . Thus, inability of the A116V and PG14 mutants to reach the cell surface does not account for the lack of ROSmediated β-cleavage of these mutants and failure to undergo β-cleavage does not correlate with a deficiency in copper-mediated endocytosis. [17] . The viability of cells expressing the various mutants of PrP was assessed by measurement of cell number using Hoescht 33342 staining. Cells expressing PrP∆oct, PG14 or A116V all displayed significantly reduced viability when challenged with H 2 O 2 and Cu 2+ as compared to cells expressing wtPrP ( p < 0.001) (Fig. 7A) . Measurement of intracellular free radical generation in the cells was made using the fluorescent dye DCF-DA in order to ascertain whether radical-mediated cell damage was altered in the cells expressing the PrP mutants. Whereas there was a significant decrease in radical formation in the wtPrP expressing cells as compared to the untransfected cells, cells expressing PrP∆oct, PG14 or A116V had a similar level of radical formation as the untransfected cells (Fig. 7B) . Glutathione peroxidase is a key component of an important antioxidant pathway in neurons, detoxifying H 2 O 2 upon glutathione oxidation. The wtPrP expressing cells had a higher level of glutathione peroxidase activity than the untransfected cells, whereas the cells expressing PrP∆oct, PG14 or A116V all had significantly reduced glutathione peroxidase activity as compared to wtPrP expressing cells (p < 0.001) (Fig. 7C ). Together these data indicate that cells expressing PrP∆oct, PG14 or A116V, none of which undergo ROS-mediated β-cleavage, were not protected against oxidative stress in the same way that cells expressing wtPrP were protected.
Failure to undergo ROS-mediated
To further examine the relationship between ROS-mediated β-cleavage and the resistance of cells to oxidative stress, we sought to block β-cleavage of wtPrP and then assess cell viability upon exposure to ROS. We reasoned that antibody SAF32 which binds to the octapeptide repeats may prevent β-cleavage. Cells expressing wtPrP were incubated in the presence of either antibody SAF32 or antibody 3F4 as control prior to exposure to Cu 2+ and H 2 O 2 ( Fig.  8) . Although the formation of C2 still occurred in cells incubated with 3F4, its production was significantly reduced by SAF32 (Fig. 8A and C) . Furthermore, cells incubated with SAF32 had a significantly lower viability when exposed to Cu 2+ and H 2 O 2 than cells exposed to either 3F4 or no antibody (Fig. 8D) , providing further evidence that β-cleavage is involved in the cellular response to oxidative stress.
C2 formed from the ROS-mediated β-cleavage of PrP
C is neither proteinase K resistant nor generated by calpains Recently it has been reported that in scrapieinfected mouse brain and cells a C2-like fragment is present that is proteinase K resistant and is generated through cleavage of PrP Sc by calpains [33] . In contrast, the C2 fragment generated from wtPrP expressed in the SH-SY5Y cells in the present study was completely proteinase K sensitive (Fig. 9A) . We examined also whether the calpain inhibitor ALLM could block the formation of C2 (Fig. 9B and D) . Interestingly, incubation of the cells with 50 µM ALLM dissolved in DMSO led to a reduction in the formation of C2. However, this was due to the free radical quenching effect of DMSO, as DMSO alone blocked the formation of C2 (Fig.  9B and D and see Fig. 3 ) and ALLM dissolved in ethanol did not inhibit the formation of C2, despite the fact that ALLM (at 10 µM) dissolved in either DMSO or ethanol completely inhibited the activity of recombinant calpain against a fluorimetric peptide substrate (Fig. 9E) . Thus the calpain inhibitor ALLM failed to block the ROSmediated β-cleavage of PrP C in the SH-SY5Y cells and the resulting C2 fragment was sensitive to proteinase K digestion.
DISCUSSION
Like many proteins PrP
C is subject to a variety of proteolytic cleavage events that may modulate its biological functions. However, the role of these cleavages and the function of the generated fragments remain to be determined. In the present study we show for the first time that the ROS-mediated β-cleavage of PrP C occurs at the cell surface, requires the octapeptide repeat region within PrP C and is defective in two forms of PrP associated with prion disease. Crucially we show that this failure to undergo ROSmediated β-cleavage correlates with an increased sensitivity of cells to oxidative stress providing the first direct evidence that β-cleavage may be a critical first step in the mechanism whereby PrP C protects cells against oxidative stress.
Although the β-cleavage of PrP C at the Cterminal end of the octapeptide repeats, near residue 90, has been observed by several groups [18, 21, 24] , the mechanism of this cleavage remained elusive until McMahon et al. [25] reported that it was ROS-mediated and Cu 2+ -dependent. These authors showed that soluble PrP in conditioned medium underwent β-cleavage upon exposure to mM concentrations of H 2 O 2 in the presence of 10 µM Cu
2+
. We have extended this observation to a more in vivo setting by showing that exposure of intact cells expressing PrP C to µM concentrations of H 2 O 2 and Cu 2+ stimulates β-cleavage as evidenced by the formation of the C-terminal fragment C2. It has been hypothesised that PrP C is involved in the cellular response mechanism to external oxidative stress, possibly acting as a sensor of ROS [34, 35] . Although it has previously been shown that ROS causes β-cleavage of soluble PrP [25] , it has not been investigated whether the β-cleavage of PrP C may be involved in the mechanism by which cells respond to oxidative stress. Our observations that surface biotinylated PrP C rapidly (within minutes) undergoes β-cleavage upon exposure of cells to ROS and that lack of β-cleavage correlates with an increased sensitivity to oxidative stress, provides the first evidence that this processing event is an early step in the cellular response to external oxidative stress.
Recently it has been reported that in scrapieinfected mouse brain and in persistently infected scrapie mouse brain cells a C2-like fragment is present that is proteinase K resistant and is generated through cleavage of PrP Sc by calpains [33] . The formation of C2 from PrP C in the SH-SY5Y cells was not blocked by a specific calpain inhibitor nor was C2 proteinase K resistant, consistent with the study of Yadavalli et al. [33] that in uninfected cells and brain tissue the observed C2 fragment is not proteinase K resistant. Thus it appears that PrP C is subject to ROS-mediated β-cleavage which produces the C2 fragment that is proteinase K sensitive, while PrP Sc is cleaved by calpain to produce a C2-like fragment that is proteinase K resistant. It is plausible that the conformational change from PrP C to PrP Sc exposes a cleavage site for calpain that is not accessible in PrP C .
Through the Fenton reaction copper (and iron) promote the formation of ROS such as the hydroxyl radical (·OH) from H 2 O 2 which, although itself not a ROS, is an important mediator of oxidative stress in neurons [16] . When the metal is protein bound, as the Cu 2+ ions are in the octapeptide repeats of PrP C , the oxidative-reduction reaction can locally generate ROS that may react at specific sites in the protein possibly resulting in peptide bond cleavage [36] . The critical involvement of ROS in the β-cleavage of PrP C is further evidenced by the inhibitory effect of the hydroxyl radical trapping agent DMSO. The importance of the Cu 2+ ions bound at the octapeptide repeats of PrP C contributing to the ROS-mediated β-cleavage is evidenced by the lack of ROSmediated cleavage of PrP∆oct which lacks the octapeptide repeats and therefore has no Cu 2+ ions bound in this region of the protein.
Although Cu 2+ binding sites downstream of the octapeptide repeats have been identified [37] [38] [39] , the Cu 2+ bound at these sites does not appear to be involved in the ROS-mediated cleavage of PrP C as evidenced by the lack of cleavage of PrP∆oct which retains these downstream Cu 2+ binding sites.
Collectively our data indicate that ROSmediated β-cleavage of PrP C may be the first step in a cascade of cellular events that lead the cell to mount a response to increased oxidative stress. Consistent with this is the observation that cells expressing wtPrP have increased viability and glutathione peroxidase activity and reduced intracellular free radicals when exposed to ROS as compared to untransfected cells, and that such protective responses to ROS are not observed in the cells expressing PrP∆oct which fails to undergo β-cleavage due to the lack of the octapeptide repeats or in cells expressing wtPrP when β-cleavage is blocked by the binding of antibody SAF32 to the octapeptide repeats.
At first sight it appears somewhat surprising that neither PG14 nor A116V were subject to ROSmediated β-cleavage. As shown in the present study (for A116V) and elsewhere (for PG14) [12, 32] this is not due to a failure of these mutants of PrP to reach the cell surface where ROS-mediated β-cleavage occurs. Furthermore, it is not linked to an inability to undergo coppermediated endocytosis as seen with both PG14 and PrP∆oct [12] , as A116V was efficiently endocytosed on incubation of the cells with copper. PG14, which contains an extra 9 copies of the octapeptide repeat, might if anything be expected to be more susceptible to copperdependent ROS-mediated cleavage. Clearly this is not the case, and the extended octapeptide repeat region, possibly through the formation of an altered relatively proteinase-resistant structure [40, 41] , may somehow prevent ROS-mediated β-cleavage. In the case of A116V why a single conservative point mutation some 25 residues away from the site of β-cleavage has such a dramatic effect is not immediately obvious. One possibility is that this mutation disrupts the folding of the polypeptide chain and thus prevents ROS-mediated β-cleavage occurring. In this context it is interesting to note that mutation of Ala113, Ala115 and Ala118 to valines enhances the folding of peptides spanning this region into compact structural units, significantly enhancing the formation of extensive β-sheet fibrils [42] .
The results of the present study do not allow us to directly address which of the proteolytic fragments, N2 or C2, produced from ROSmediated β-cleavage of PrP C is responsible for propagating the survival signal. The soluble N2 fragment may act as a signalling molecule analogous to peptide growth factors [34] . In support of this is the observation that deletion of the N-terminal residues 23-88 from PrP abrogates the potential to rescue PrP-deficient mice from Doppel-induced neurodegeneration [43] and that cells expressing a construct of PrP in which the N-terminus is tethered to the membrane through an uncleaved signal peptide/transmembrane anchor are severely compromised in their resistance to oxidative stress [17] . Alternatively, it has been suggested that the GPI-anchored C2 fragment is important in mediating the cellular response to oxidative stress via dimerisation and activation of signal transduction pathways [35] and that the protective function of C2 is turned off by subsequent α-cleavage to generate C1 [22] . Thus, that there is a precursor-product relationship between the C2 and C1 fragments. However, our data would argue against such a relationship as although PrP∆oct, PG14 and A116V all fail to produce C2, they all produced similar amounts of C1 as wtPrP. Rather, we favour the scenario that the α-and β-cleavages of PrP C are independent proteolytic events similar to the α-and β-cleavages of the Alzheimer's amyloid precursor protein [44] .
The observation that ROS-mediated β-cleavage of PrP C is defective in the two disease associated mutants PG14 and A116V adds further weight to the argument that prion diseases are, in part, due to the loss of a normal function of PrP C [4] . Clearly the inability of cells expressing the disease-associated PG14 and A116V mutants to mount a protective response against oxidative stress would be detrimental. There is increasing evidence that oxidative stress is involved in prion diseases [45] [46] [47] . This could come about because on conversion to PrP Sc , PrP C is no longer available to be subject to ROS-mediated β-cleavage as part, possibly the first step, of the cellular mechanism to protect against oxidative stress. In cases of prion disease due to mutation in PrP, such as in PG14 and A116V, that prevent ROS-mediated β-cleavage of PrP C , the normal cellular response to oxidative stress is compromised and this in turn may contribute to the neurodegeneration observed.
Abbreviations used: ADAM, a disintegrin and metalloprotease; ALLM, N-Acetyl-Leu-Leu-Met-CHO; DCF-DA, dihydrodichlorofluorescein diacetate; DMSO, dimethyl sulphoxide; FCS, fetal calf serum; PBS, phosphate-buffered saline; PI-PLC, phosphatidylinositol-specific phospholipase C; PNGase F, Peptide:Nglycosidase F; PrP 
